Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Methylated genes in breast cancer: associations with clinical and histopathological features in a familial breast cancer cohort.

Swift-Scanlan T, Vang R, Blackford A, Fackler MJ, Sukumar S.

Cancer Biol Ther. 2011 May 15;11(10):853-65. Epub 2011 May 15.

2.

Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.

Sunami E, Shinozaki M, Sim MS, Nguyen SL, Vu AT, Giuliano AE, Hoon DS.

Breast Cancer Res. 2008;10(3):R46. doi: 10.1186/bcr2098. Epub 2008 May 16.

3.

Methylation is less abundant in BRCA1-associated compared with sporadic breast cancer.

Suijkerbuijk KP, Fackler MJ, Sukumar S, van Gils CH, van Laar T, van der Wall E, Vooijs M, van Diest PJ.

Ann Oncol. 2008 Nov;19(11):1870-4. doi: 10.1093/annonc/mdn409. Epub 2008 Jul 22.

4.

RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.

Sebova K, Zmetakova I, Bella V, Kajo K, Stankovicova I, Kajabova V, Krivulcik T, Lasabova Z, Tomka M, Galbavy S, Fridrichova I.

Cancer Biomark. 2011-2012;10(1):13-26. doi: 10.3233/CBM-2012-0230.

PMID:
22297548
5.

Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis.

Shinozaki M, Hoon DS, Giuliano AE, Hansen NM, Wang HJ, Turner R, Taback B.

Clin Cancer Res. 2005 Mar 15;11(6):2156-62.

6.

PTPRO promoter methylation is predictive of poorer outcome for HER2-positive breast cancer: indication for personalized therapy.

Huang YT, Li FF, Ke C, Li Z, Li ZT, Zou XF, Zheng XX, Chen YP, Zhang H.

J Transl Med. 2013 Oct 3;11:245. doi: 10.1186/1479-5876-11-245.

7.

Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.

Fiolka R, Zubor P, Janusicova V, Visnovsky J, Mendelova A, Kajo K, Lasabova Z, Plank L, Danko J.

Oncol Rep. 2013 Dec;30(6):2878-86. doi: 10.3892/or.2013.2752. Epub 2013 Sep 25.

PMID:
24068440
8.

DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status.

Flanagan JM, Cocciardi S, Waddell N, Johnstone CN, Marsh A, Henderson S, Simpson P, da Silva L; kConFab Investigators., Khanna K, Lakhani S, Boshoff C, Chenevix-Trench G.

Am J Hum Genet. 2010 Mar 12;86(3):420-33. doi: 10.1016/j.ajhg.2010.02.008. Epub 2010 Mar 4.

9.

DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival.

Conway K, Edmiston SN, May R, Kuan PF, Chu H, Bryant C, Tse CK, Swift-Scanlan T, Geradts J, Troester MA, Millikan RC.

Breast Cancer Res. 2014 Oct 7;16(5):450. doi: 10.1186/s13058-014-0450-6.

10.

Quantitative promoter hypermethylation profiles of ductal carcinoma in situ in North American and Korean women: Potential applications for diagnosis.

Lee JS, Fackler MJ, Teo WW, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Argani P, Sukumar S.

Cancer Biol Ther. 2008 Sep;7(9):1398-406. Epub 2008 Sep 4.

PMID:
18769130
11.

Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women.

Jing MX, Mao XY, Li C, Wei J, Liu C, Jin F.

Tumour Biol. 2011 Aug;32(4):713-9. doi: 10.1007/s13277-011-0172-7. Epub 2011 Apr 6.

PMID:
21625942
12.

Basal-like breast cancer displays distinct patterns of promoter methylation.

Lee JS, Fackler MJ, Lee JH, Choi C, Park MH, Yoon JH, Zhang Z, Sukumar S.

Cancer Biol Ther. 2010 Jun 15;9(12):1017-24. Epub 2010 Jun 18.

13.

Quantitative DNA methylation analyses reveal stage dependent DNA methylation and association to clinico-pathological factors in breast tumors.

Klajic J, Fleischer T, Dejeux E, Edvardsen H, Warnberg F, Bukholm I, Lønning PE, Solvang H, Børresen-Dale AL, Tost J, Kristensen VN.

BMC Cancer. 2013 Oct 5;13:456. doi: 10.1186/1471-2407-13-456.

14.

Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.

Matuschek C, Bölke E, Lammering G, Gerber PA, Peiper M, Budach W, Taskin H, Prisack HB, Schieren G, Orth K, Bojar H.

Eur J Med Res. 2010;15:277-86.

15.

Phenotypic analysis of familial breast cancer: comparison of BRCAx tumors with BRCA1-, BRCA2-carriers and non-familial breast cancer.

Aloraifi F, Alshehhi M, McDevitt T, Cody N, Meany M, O'Doherty A, Quinn CM, Green AJ, Bracken A, Geraghty JG.

Eur J Surg Oncol. 2015 May;41(5):641-6. doi: 10.1016/j.ejso.2015.01.021. Epub 2015 Feb 17.

PMID:
25736863
16.

Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls.

Sturgeon SR, Balasubramanian R, Schairer C, Muss HB, Ziegler RG, Arcaro KF.

Epigenetics. 2012 Nov;7(11):1258-67. doi: 10.4161/epi.22220. Epub 2012 Sep 17.

17.

Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.

Fumagalli C, Pruneri G, Possanzini P, Manzotti M, Barile M, Feroce I, Colleoni M, Bonanni B, Maisonneuve P, Radice P, Viale G, Barberis M.

Breast Cancer Res Treat. 2012 Jul;134(1):131-7. doi: 10.1007/s10549-011-1945-9. Epub 2012 Jan 8.

PMID:
22228432
18.

Prognostic significance of gene-specific promoter hypermethylation in breast cancer patients.

Cho YH, Shen J, Gammon MD, Zhang YJ, Wang Q, Gonzalez K, Xu X, Bradshaw PT, Teitelbaum SL, Garbowski G, Hibshoosh H, Neugut AI, Chen J, Santella RM.

Breast Cancer Res Treat. 2012 Jan;131(1):197-205. doi: 10.1007/s10549-011-1712-y. Epub 2011 Aug 12.

19.

DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma.

Fackler MJ, McVeigh M, Evron E, Garrett E, Mehrotra J, Polyak K, Sukumar S, Argani P.

Int J Cancer. 2003 Dec 20;107(6):970-5.

20.

Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.

Karray-Chouayekh S, Trifa F, Khabir A, Boujelbane N, Sellami-Boudawara T, Daoud J, Frikha M, Jlidi R, Gargouri A, Mokdad-Gargouri R.

J Cancer Res Clin Oncol. 2010 Feb;136(2):203-10. doi: 10.1007/s00432-009-0649-6. Epub 2009 Aug 6.

PMID:
19657672

Supplemental Content

Support Center